In June 2020 NOKLUS (Norwegian Quality Improvement of Primary Health Care Laboratories) evaluated the diagnostic accuracy and user-friendliness of 17 rapid tests for the detection of anti-SARS CoV-2 antibodies.

At the end of June, we received a visit from Kerstin Radomski, Member of the German Bundestag for (among others) Moers as well as rapporteur of the Budget Committee on the budget of the Federal Ministry of Education and Research. One of the reasons for this visit was the commitment to funding from the German government for a nal von minden GmbH project...

Until now, RT-PCR has been the gold standard in testing for the novel SARS-CoV-2 virus, which causes COVID-19 (colloquially known as ‘coronavirus’) infection. However, this type of laboratory test costs several hundred euros per suspected case, and results can sometimes take days to obtain. With European laboratories increasingly overburdened, this tendency is growing. In-vitro diagnostics can help.

Before selling or further processing hemp, pharmacies in most countries are obliged to check whether their delivery is CBD or THC-based. For self-explanatory reasons, it is important for police, customs and jails to distinguish between legal and illegal plant material also.

On 26th May 2017, the new guidelines for in-vitro diagnostics (IVDR) came into force across the EU. As of that date, manufacturers have a 5-year transition period, ending in May 2022, to implement the often time-consuming and labour-intensive changes.